Get started
AdvisorShares Trust AdvisorShares Pure US Cannabis ETFAdvisorShares Trust AdvisorShares Pure US Cannabis ETFAdvisorShares Trust AdvisorShares Pure US Cannabis ETF

AdvisorShares Trust AdvisorShares Pure US Cannabis ETF

No trades
See on Supercharts
Overview Analysis News
Ideas
Discussions Technicals Seasonals Options

MSOS trade ideas

MSOS is oversold now. Looking for a possible bottom in the 29sRSI in oversold levels and finished the day with a nice hammer candle. Shooting my shot and hoping this is near its bottom. Weed industry is going to be here in the long run whether people like it or not. Whether it can be profitable remains in the hands of lawmakers, and that is the only thing that makes me a tiny bit nervous about this trade. Also the weed ETF space is beginning to get a little crowded for my liking. With that being said, I expect this ticker to find support near the $30 level with an eventual bounce back into the low to mid 30s. This would also be a nice accumulation play for those looking to hold something long term. 100% American weed companies in this ETF, and that is where the money is going to be as soon as legislation/legalization happens. These companies have been beaten down for 7 months straight now, even while reporting positive numbers growth. Eventually a value is a value and this will shoot up for those who are patient.
AMEX:MSOSLong
by DrewDimes
What Is The Best Way To Bet On The Cannabis Industry?-- With Senate Majority Leader Chuck Schumer proposing legislation on Wednesday to federally legalize Cannabis, it's important to analyze what ETF options investors have to invest in the budding sector. -- There are many different ETFs, each with different liquidity profiles, investment strategies, and geographical focuses. -- MSOS and YOLO are the best positioned to take advantage of the shifting legislative landscape. With the potential federal legalization of cannabis around the corner, I figured now might be a good time to take a look at what options exist for those looking to invest in the sector, by comparing all of the available ETFs that are currently on offer and getting a better understanding of each of their respective profiles. In this article, I will break down each of these ETFs to attempt to determine which investments offer the most compelling risk / reward tradeoff. Currently, there are a total of 7 investable ETFs that focus on cannabis cultivation, production, distribution, use, etc. Below, they are listed by daily trading volume. Ticker Daily Volume (in USD) Total Assets (in USD) Expense Ratio: MSOS $21.5M $561M 0.74% MJ $18.9M $1.52B 0.75% YOLO $3.7M $346M 0.75% POTX $3M $178M 0.51% CNBS $2.5M $142M 0.75% THCX $1.5M $151M 0.75% TOKE $283K $39M 0.42% Unfortunately, generally, liquidity is incredibly low in the space, with only a combined $51 million dollars worth of shares trading hands on the average day. Additionally, TOKE is also effectively disqualified from consideration, given its low level of average volume. At the top of the heap, there are two ETFs that clearly stick out from the pack when it comes to AUM and Liquidity: MSOS and MJ. Lets begin there. MSOS Launched in September of last year, MSOS is the only ETF that is purely invested in companies serving the U.S. market. Specifically, "The Fund invests at least 80% of its net assets in securities of companies that derive at least 50% of their net revenue from the marijuana and hemp business in the United States, and in derivatives that have economic characteristics similar to such securities." As it turns out, that last bit of jargon plays a significant role in understanding the composition of the ETF. Summarized, MSOS's top underlying holdings are: Green Thumb Industries (GTBIF), Curaleaf Holdings (CURLF), Trulieve Cannabis (TCNNF), Cresco Labs (CRLBF), Ayr Wellness (AYRWF), Terrascend Corp (TRSSF), IIPR, HarvestHealth (HRVSF) , GRWG, Columbia Care (CCHWF), 4front Ventures (FFNTF), and Planet 13 Holdings (PLNHF). However, the fund achieves its investment objectives by almost completely allocating capital via total return swaps on those equities (a decision that was likely made due to the OTC nature of the underlying securities), which can obscure exactly how the ETF is positioned. Symbol Name % Weight -- Green Thumb Industries Swap Rec 9.64% -- Curaleaf Holdings Inc Swap Rec 8.16% -- Trulieve Cannabis Swap Rec 7.85% -- Cresco Labs Inc Swap Rec 6.30% -- Rec Ayr Wellness Inc 5.61% -- Terrascend Corp Swap Rec 4.91% IIPR Innovative Industrial Properties Inc 4.43% -- Harvesthealth Swap R 4.40% GRWG GrowGeneration Corp 4.08% -- Curaleaf Holdings Inc Swap Rec 3.64% -- Swap on Green Thumb Industries Inc 3.34% -- Cresco Labs Inc Swap Rec 3.17% -- Trulieve Cannabis Swap Rec 3.07% -- Columbia Care Inc Swap Rec 2.73% -- 4front Ventures Corp Swap Rec 2.41% -- Planet 13 Holdings Swap Rec 2.34% -- Jushi Holdings Inc Swap Pay -2.31% -- Planet 13 Holdings Swap Pay -2.51% -- Columbia Care Inc Swap Pay -2.60% -- Terrascend Corp Swap Pay -5.34% -- Pay Ayr Wellness Inc -5.61% -- Cresco Labs Inc Swap Pay -6.41% -- Trulieve Cannabis Swap Pay -7.76% -- Curaleaf Holdings Inc Swap Pay -8.27% -- Green Thumb Industries Swap Pay -9.73% While the ETF's capital is deployed in a relatively unconventional manner, the potential upside here (given federal legalization) is huge, and three fold. U.S. based producers and multi-state operators would likely see the biggest operational upside in a best case legislative scenario, as conducting business and expanding in the core U.S. market becomes significantly less of a headache. Additionally, some estimates put the U.S. cannabis market at over 90% of the global cannabis market, which should obviously benefit the entrenched players the most. Finally, if legalized, it is likely that many of the multi-state operators MSOS holds could/would begin to trade as listed companies on regulated exchanges, which should increase their access to capital and broaden analyst coverage by the investment community. Even if cannabis isn't legalized anytime soon, MSOS's portfolio companies are currently trading at a relative discount to Canadian/Global producers, like CGC, CRON, TLRY and ACB. On average, MSOS's cultivator holdings are trading at a 6.1x FWD Sales multiple, while the four biggest global producers I just mentioned are trading at an average 19.3x FWD Sales multiple, more than triple their U.S. counterparts. This premium is likely due to a combination of factors, including the fact that the global market is growing more quickly, and that the Global operations have more ready access to capital to achieve that growth. The flip side is that MSOS is both a relative value and provides the most leverage to a legalization scenario within the United States. MJ If MSOS was the cheap, concentrated U.S. play, then MJ is the more expensive, broad, global play. Launched in late 2015, the ETF seeks to track the performance of the "Prime Alternative Harvest Index", which invests in Cannabis companies, Pharmaceutical companies (that utilize cannabinoids as active ingredients), Tobacco companies, and Agricultural Equipment companies. By taking this broad approach to the sector, many of the risks that one takes by directly investing in production are dampened by the established, legal markets that pharma, tobacco, and agribusiness supply all serve. Despite this broad mandate, the majority of the top holdings in the fund are direct allocations to the expensive, Canadian-listed operators like TLRY, CGC and CRON that were mentioned previously, which means that the fund should still participate in some upside should the best case play out in Congress over the coming months. Symbol Name % Weight GRWG GrowGeneration Corp 9.30% TLRY Tilray Inc 8.49% WEED.TO Canopy Growth Corp 7.19% ACB.TO Aurora Cannabis Inc 6.11% CRON.TO Cronos Group Inc 6.01% VALT ETFMG Sit Ultra Short ETF 5.39% HEXO.TO HEXO Corp 4.11% OGI.TO OrganiGram Holdings Inc 3.90% VFF.TO Village Farms International Inc 3.78% ARNA Arena Pharmaceuticals Inc 3.26% TPB Turning Point Brands Inc 3.03% JAZZ Jazz Pharmaceuticals PLC 3.01% VGR Vector Group Ltd 2.94% PM Philip Morris International Inc 2.93% IMB Imperial Brands PLC 2.88% XXII 22nd Century Group Inc 2.82% BATS British American Tobacco PLC 2.82% MO Altria Group Inc 2.75% SWM Schweitzer-Mauduit International Inc 2.45% SMG The Scotts Miracle Gro Co 2.32% CWEB.TO Charlottes Web Holdings Inc 2.12% VLNS.TO The Valens Co Inc 1.78% HYFM Hydrofarm Holdings Group Inc 1.72% CRBP Corbus Pharmaceuticals Holdings Inc 1.45% ZYNE Zynerba Pharmaceuticals Inc 1.40% While MJ remains balanced in its approach, investing in things as far flung as Scott's Miracle Grow (SMG) to Jazz pharmaceuticals (JAZZ), the expensive concentration to the non-U.S. operators I still view as suboptimal when compared to something like MSOS. There's no doubt that there's still upside to all cannabis should legalization happen, but the lack of direct U.S. exposure, combined with an already raised average valuation multiple means that the upside involved looks much less enticing than exposure to U.S. names. YOLO If MJ and MSOS had a frankenbaby, it would look a lot like YOLO. From the same fund management company as MSOS, YOLO takes some of the U.S. total return swap multi-state operator exposure, and combines it with some of the more global investment mandate of MJ, as the portfolio includes a few tangential positions, like Arena Pharmaceuticals (ARNA) and YCBD. The portfolio also includes a hefty weighting to Treasuries, presumably there at the moment to dampen fund return amplitude while waiting to pounce on potential opportunities. The fund prospectus does not mention this allocation, and thus it appears to be a transitory position. The fund has a higher concentration of both U.S. and global cannabis producers than either MJ or MSOS, and it is perhaps the single most pure play hybrid cannabis producer ETF on the market. In addition, the fund has a nearly 15% allocation to VFF, an underlying equity I have a very positive view on; VFF remains one of the only companies with both U.S. and Global exposure, and it's trading at only 3.43x FWD Sales. Symbol Name % Weight TTTXX BlackRock Liquidity Treasury Instl 26.41% VFF.TO Village Farms International Inc 14.49% IIPR Innovative Industrial Properties Inc 10.99% -- Swap on Green Thumb Industries Inc 6.99% GRWG GrowGeneration Corp 6.83% -- Swap on Curaleaf Holdings Inc 6.13% TLRY Tilray Inc 5.97% WEED.TO Canopy Growth Corp 5.91% -- Harvesthealth Swap R 5.30% -- Swap on Cresco Labs Inc 4.98% -- Swap on Trulieve Cannabis Corp Ordinary Shares (Sub Voting) 4.80% -- Columbia Care Inc Swap Rec 4.33% -- Terrascend Corp Swap Rec 3.40% RIV.TO RIV Capital Inc 2.71% ARNA Arena Pharmaceuticals Inc 2.25% JAZZ Jazz Pharmaceuticals PLC 1.52% CWEB.TO Charlottes Web Holdings Inc 1.52% VLNS.TO The Valens Co Inc 1.36% YCBD cbdMD Inc 1.00% CRDL.TO Cardiol Therapeutics Inc 0.82% -- Columbia Care Inc Swap Pay -3.69% -- Swap on Trulieve Cannabis Corp Ordinary Shares (Sub Voting) -4.90% -- Swap on Cresco Labs Inc -5.02% -- Swap on Curaleaf Holdings Inc -6.10% -- Swap on Green Thumb Industries Inc -6.88% While YOLO lacks some of the focus and leverage that MSOS has to a federal legalization outcome, the smart overall allocations, treasury position, and global reach make this one worth considering. POTX Launched in September 2019, POTX has remained one of the smaller ETFs in terms of AUM, which is likely due to its generally unfavorable investment strategy. This strategy mirror's MJ's non-U.S., global only approach. The main difference is that POTX's portfolio tracks the "Cannabis Index" run by Solactive AG, which lacks all of the broader and tangential investment mandates that are meant to buoy and diversify MJ's portfolio. What you end up with is a laundry list of expensive global operators with little to no U.S. exposure and neither the capital nor the will to truly make a dent in the U.S. market, even when/if allowed. Symbol Name % Weight WEED.TO Canopy Growth Corp 10.79% SNDL Sundial Growers Inc 9.22% CRON.TO Cronos Group Inc 9.10% ACB.TO Aurora Cannabis Inc 8.58% HEXO.TO HEXO Corp 8.21% TLRY Tilray Inc 8.15% OGI.TO OrganiGram Holdings Inc 5.14% CWEB.TO Charlottes Web Holdings Inc 4.32% RIV.TO RIV Capital Inc 4.21% CRBP Corbus Pharmaceuticals Holdings Inc 3.87% ZYNE Zynerba Pharmaceuticals Inc 3.73% -- The Valens Co Inc 3.69% XLY.TO Auxly Cannabis Group Inc 3.04% -- Green Organic Dutchman Hldgs 2.66% PCLO.V PharmaCielo Ltd 2.11% -- Fire & Flower Inc 2.07% AH.TO Aleafia Health Inc 2.00% LABS.TO MediPharm Labs Corp 1.64% TBP.TO Tetra Bio Pharma Inc 1.60% YCBD cbdMD Inc 1.54% CPH Creso Pharma Ltd 1.54% CRDL.TO Cardiol Therapeutics Inc 1.52% CAN Cann Group Ltd 1.36% With POTX, you're only getting the global, expensive, non-legalization leverage producing Canadian-listed operators, which are all set to produce less than exciting relative performance over the medium term. Add to that a top two holding of SNDL, which trades at 40x FWD Sales, and POTX is nothing but a hard pass in my view. CNBS Launched in July of 2019, CNBS is a bit of an oddity within the Cannabis ETF space. Out of its top 10 holdings, only 4 are actual cannabis producers, as Tim Seymour, the portfolio manager, seems to be more interested in the ancillary businesses that win as the industry, overall, globally, grows. From AFC Gamma (The biggest cannabis financing firm) to Hydrofarm (grow beds and lighting), CNBS really seems to be the picks and shovels play within the cadre of available ETF options. There's still some direct exposure to the producer-end of the value chain with allocations to TLRY, CGC, VFF, and CRON, but that's not where the focus is. Symbol Name % Weight MAPS WM Technology Inc 10.00% TLRY Tilray Inc 9.58% VFF.TO Village Farms International Inc 8.00% WEED.TO Canopy Growth Corp 7.88% IIPR Innovative Industrial Properties Inc 6.52% AFCG AFC Gamma Inc 6.50% HYFM Hydrofarm Holdings Group Inc 6.48% GRWG GrowGeneration Corp 6.45% CRON.TO Cronos Group Inc 4.31% RIV.TO RIV Capital Inc 4.01% VLNS.TO The Valens Co Inc 3.57% GNLN Greenlane Holdings Inc 3.56% CWEB.TO Charlottes Web Holdings Inc 3.49% JAZZ Jazz Pharmaceuticals PLC 3.10% CARA Cara Therapeutics Inc 2.33% CLVR Clever Leaves Holdings Inc 2.18% OGI.TO OrganiGram Holdings Inc 2.13% NEPT.TO Neptune Wellness Solutions Inc 1.63% YCBD cbdMD Inc 1.33% ZYNE Zynerba Pharmaceuticals Inc 1.14% PKI PerkinElmer Inc 1.02% LABS.TO MediPharm Labs Corp 1.00% -- Swap on Green Thumb Industries Inc 0.91% KERN Akerna Corp 0.83% XLY.TO Auxly Cannabis Group Inc 0.56% If this ETF had exposure to some of the U.S. MSO's, it would be in a great place. For investors who want to play cannabis without taking too much producer risk, it's a great option. However, it lacks the same level of leverage to legalization that MSOS and YOLO have. THCX Last, but not least, we come to THCX. Honestly, there isn't much to say about this fund. Its portfolio is varied, and it has exposure to a blend of producers, equipment manufacturers, and cannabinoid end-users. However, nothing within the portfolio really stands out, and with high concentrations in the expensive TLRY, CRON, CGC, and ACB, along with an uncompetitive expense ratio and poor market liquidity, there's no reason to dig deeper here. Plus, it lacks exposure to a boom in the U.S. cannabis industry, aside from the ubiquitous pick and shovel plays in GRWG, HYFM, and SMG. Symbol Name % Weight TLRY Tilray Inc 6.89% WEED.TO Canopy Growth Corp 6.53% VFF Village Farms International Inc 5.93% GRWG GrowGeneration Corp 5.52% CRON Cronos Group Inc 4.88% AMRS Amyris Inc 4.69% HYFM Hydrofarm Holdings Group Inc 4.63% OGI OrganiGram Holdings Inc 4.50% FAF.TO Fire & Flower Holdings Corp 4.50% RIV.TO RIV Capital Inc 4.41% VLNS.TO The Valens Co Inc 3.42% YCBD cbdMD Inc 3.22% SMG The Scotts Miracle Gro Co 2.92% ACB.TO Aurora Cannabis Inc 2.57% LABS.TO MediPharm Labs Corp 2.49% WAT Waters Corp 2.44% CBWTF Auxly Cannabis Group Inc 2.44% CLVR Clever Leaves Holdings Inc 2.40% GNLN Greenlane Holdings Inc 2.37% AGFY Agrify Corp 2.36% HEXO HEXO Corp 2.29% PKI PerkinElmer Inc 2.20% HITI.V High Tide Inc 2.07% CWEB.TO Charlottes Web Holdings Inc 2.02% NWVCF EnWave Corp 1.96% Summary While there are a number of options to choose from when it comes to betting on the cannabis industry, MSOS and YOLO emerge as the top two ETF picks for betting on imminent federal legalization within the United States, due to their producer-first focus, and relatively attractive average valuation entry points. CNBS also stands out as a good picks and shovels play, but should see less overall upside in the event of a best case outcome in Congress.
AMEX:MSOSLong
by PropNotes
MSOS- Sure winner with patienceMSOS is a pure US Cannabis ETF. PURE US being the key there. Forget about Canadian weed, America is where the money is. Legalization/De-criminalization is bound to happen. When it does, the run-up will be intense. This industry is still young and much like legalized gambling, one by one, the states are getting in on the action. This means guaranteed market growth YOY. Instead of trying to pick one company these guys give you a nice basket of them because who knows which company will boom or be bought out by big money. Only downside is that we are depending on politics as the major catalyst to boost our bank accounts. We know how slow politics move and how little our politicians want to do for us if it doesn't mean putting more in their back pocket. So stay patient and accumulate! Currently it looks like we may be breaking out of the falling wedge after months of accumulation. Also showed a nice bounce up off the 200 day moving average, and just broke thru and closed above the 50 day moving average on Friday. I may have jumped the gun drawing my channel, but the upwards movement has to start somewhere. Let's hope 38-40 was the bottom. Fairly confident we will see $50's by early 2022 so enter as you wish.
AMEX:MSOSLong
by DrewDimes
$MSOS sending SOSFirst US cannabis ETF is gapping down, both longs and shorts are fair and reasonable. Longs: - Bottom of channel will be retested soon and may bounce. - Gap shall be closed and may bounce. - Once year open retested it may bounce. - I'm not watching news so I have no clue what they say on CNBC. Shorts: - Formation of H&S pattern, therefore measured move possible. - If year open does not hold, we will be gapping down all the way to the beginning of the bullish cycle for retest. - Usually new asset formation includes some form of the squeeze. They want all your money therefore they will trigger every stop on the way. Not financial advise.
AMEX:MSOSShort
by LEVERXYZ
$MSOS Pot Stocks not Smoked Yet The volatility in the pot stocks has been hard to stomach for most short term investors as we can see by the huge volume recently as the run for the hills. For those still holding , Fridays action should offer some encouragement as we seen a great late day reversal. When we look at the chart we also see that the gap up was held. the POC although breached was reclaimed as support. Lets see can the capitulation lead to a recovery prior to the quarterly options expiration this month which will lead to volatility .
AMEX:MSOSLong
by Xclusive-Trading
2